Wearable Health Solutions, Inc. (WHSI)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 2.63 Million USD | 61.04% |
| 2022 | 1.63 Million USD | -9.84% |
| 2021 | 1.81 Million USD | 4.05% |
| 2020 | 1.74 Million USD | 47.31% |
| 2019 | 1.18 Million USD | 4.52% |
| 2018 | 1.13 Million USD | 10.3% |
| 2017 | 1.02 Million USD | 36.51% |
| 2016 | 751.18 Thousand USD | 58.83% |
| 2015 | 472.95 Thousand USD | 1935.55% |
| 2014 | 23.23 Thousand USD | -97.4% |
| 2013 | 892.48 Thousand USD | 407.82% |
| 2012 | 175.74 Thousand USD | -16.46% |
| 2011 | 210.37 Thousand USD | -17.89% |
| 2010 | 256.21 Thousand USD | -62.24% |
| 2009 | 678.54 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 2.49 Million USD | -5.22% |
| 2024 Q2 | 2.36 Million USD | -4.99% |
| 2023 FY | 2.63 Million USD | 61.04% |
| 2023 Q1 | 1.47 Million USD | -9.59% |
| 2023 Q4 | 2.63 Million USD | 36.37% |
| 2023 Q3 | 1.92 Million USD | 2.64% |
| 2023 Q2 | 1.87 Million USD | 27.27% |
| 2022 FY | 1.63 Million USD | -9.84% |
| 2022 Q1 | 528.23 Thousand USD | -70.85% |
| 2022 Q2 | 139.03 Thousand USD | -73.68% |
| 2022 Q3 | 1.02 Million USD | 639.88% |
| 2022 Q4 | 1.63 Million USD | 58.83% |
| 2021 Q3 | 2.72 Million USD | 0.0% |
| 2021 FY | 1.81 Million USD | 4.05% |
| 2021 Q4 | 1.81 Million USD | -33.62% |
| 2021 Q1 | 2.33 Million USD | 34.17% |
| 2020 Q3 | 1.55 Million USD | 10.6% |
| 2020 FY | 1.74 Million USD | 47.31% |
| 2020 Q1 | 1.35 Million USD | 14.95% |
| 2020 Q2 | 1.4 Million USD | 3.67% |
| 2020 Q4 | 1.74 Million USD | 11.76% |
| 2019 Q3 | 1.17 Million USD | 0.0% |
| 2019 FY | 1.18 Million USD | 4.52% |
| 2019 Q2 | 1.17 Million USD | -0.38% |
| 2019 Q1 | 1.17 Million USD | 4.22% |
| 2019 Q4 | 1.18 Million USD | 0.67% |
| 2018 Q1 | 1.11 Million USD | 8.68% |
| 2018 FY | 1.13 Million USD | 10.3% |
| 2018 Q4 | 1.13 Million USD | -0.81% |
| 2018 Q3 | 1.14 Million USD | 2.46% |
| 2018 Q2 | 1.11 Million USD | -0.14% |
| 2017 Q4 | 1.02 Million USD | 8.54% |
| 2017 Q3 | 944.8 Thousand USD | 57.79% |
| 2017 Q2 | 598.76 Thousand USD | -32.88% |
| 2017 Q1 | 892.09 Thousand USD | 18.76% |
| 2017 FY | 1.02 Million USD | 36.51% |
| 2016 Q4 | 751.18 Thousand USD | 10.16% |
| 2016 Q2 | 494.77 Thousand USD | 1.53% |
| 2016 Q1 | 487.29 Thousand USD | 3.03% |
| 2016 Q3 | 681.89 Thousand USD | 37.82% |
| 2016 FY | 751.18 Thousand USD | 58.83% |
| 2015 Q3 | 394.15 Thousand USD | 45.81% |
| 2015 Q4 | 472.95 Thousand USD | 19.99% |
| 2015 Q1 | 103.36 Thousand USD | 344.87% |
| 2015 FY | 472.95 Thousand USD | 1935.55% |
| 2015 Q2 | 270.32 Thousand USD | 161.53% |
| 2014 Q3 | 43.66 Thousand USD | -21.93% |
| 2014 FY | 23.23 Thousand USD | -97.4% |
| 2014 Q4 | 23.23 Thousand USD | -46.79% |
| 2014 Q2 | 55.92 Thousand USD | -94.07% |
| 2014 Q1 | 943.03 Thousand USD | 5.66% |
| 2013 Q1 | 2.69 Million USD | 1434.4% |
| 2013 Q2 | 228.55 Thousand USD | -91.52% |
| 2013 Q3 | 176.85 Thousand USD | -22.62% |
| 2013 Q4 | 892.48 Thousand USD | 404.64% |
| 2013 FY | 892.48 Thousand USD | 407.82% |
| 2012 Q2 | 249.79 Thousand USD | 13.57% |
| 2012 Q3 | 708.33 Thousand USD | 183.56% |
| 2012 Q4 | 175.74 Thousand USD | -75.19% |
| 2012 FY | 175.74 Thousand USD | -16.46% |
| 2012 Q1 | 219.95 Thousand USD | 4.55% |
| 2011 Q1 | 271.76 Thousand USD | 6.07% |
| 2011 Q2 | 282.88 Thousand USD | 4.09% |
| 2011 Q4 | 210.37 Thousand USD | -25.43% |
| 2011 FY | 210.37 Thousand USD | -17.89% |
| 2011 Q3 | 282.13 Thousand USD | -0.27% |
| 2010 Q2 | 536.72 Thousand USD | 28.6% |
| 2010 FY | 256.21 Thousand USD | -62.24% |
| 2010 Q4 | 256.21 Thousand USD | -57.16% |
| 2010 Q3 | 598.1 Thousand USD | 11.44% |
| 2010 Q1 | 417.37 Thousand USD | -38.49% |
| 2009 Q3 | 237.31 Thousand USD | -89.89% |
| 2009 Q4 | 678.54 Thousand USD | 185.93% |
| 2009 Q1 | -448.8 Thousand USD | 0.0% |
| 2009 Q2 | 2.34 Million USD | 623.16% |
| 2009 FY | 678.54 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| American Medical Technologies Inc. | 479.63 Thousand USD | -448.592% |
| Ansell Limited | -54.99 Million USD | 104.784% |
| Ansell Limited | -55.1 Million USD | 104.775% |
| BG Medicine, Inc. | - USD | -Infinity% |
| Biotage AB (publ) | -36.49 Million USD | 107.21% |
| BioLife Sciences Inc. | - USD | -Infinity% |
| CB Scientific, Inc. | -105.1 Thousand USD | 2603.491% |
| Psykey, Inc. | 634.59 Thousand USD | -314.631% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.781% |
| ConvaTec Group Plc | 1.2 Billion USD | 99.781% |
| Encision Inc. | 1.29 Million USD | -103.861% |
| Golden Valley Development, Inc | - USD | -Infinity% |
| Hear AtLast Holdings, Inc. | 2.3 Million USD | -13.969% |
| Innovative MedTech Inc. | 1.76 Million USD | -49.1% |
| LifePoint, Inc. | -3.26 Million USD | 180.613% |
| Medite Cancer Diagnostics, Inc. | 4.9 Million USD | 46.347% |
| Paradigm Medical Industries, Inc. | 2.16 Million USD | -21.703% |
| QuantRx Biomedical Corporation | - USD | -Infinity% |
| Remedent, Inc. | -43.3 Thousand USD | 6176.157% |
| Reflect Scientific, Inc. | -1.03 Million USD | 354.149% |
| SmileDirectClub, Inc. | 778.67 Million USD | 99.662% |
| Sector 10, Inc. | 163 Thousand USD | -1514.245% |
| Shandong Weigao Group Medical Polymer Company Limited | -417.55 Million USD | 100.63% |
| SheerVision, Inc. | 57.34 Thousand USD | -4488.082% |
| United Health Products, Inc. | 660.56 Thousand USD | -298.326% |
| Vasamed, Inc. | 22.12 Thousand USD | -11794.128% |
| Yubo International Biotech Limited | 772.27 Thousand USD | -240.708% |